Vaxxa AB (NGM:VAXXA)
Sweden · Delayed Price · Currency is SEK 0.4930
-0.0050 (-1.00%)
At close: Jul 30, 2026
Vaxxa AB Revenue
Vaxxa AB had revenue of 29.79M SEK in the quarter ending June 30, 2026, with 50.54% growth. This brings the company's revenue in the last twelve months to 92.78M, up 26.16% year-over-year. In the year 2025, Vaxxa AB had annual revenue of 77.45M, down -8.01%.
Revenue (ttm)
92.78M
Revenue Growth
+26.16%
P/S Ratio
0.23
Revenue / Employee
11.60M
Employees
8
Market Cap
21.38M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 77.45M | -6.74M | -8.01% |
| Dec 31, 2024 | 84.19M | 30.61M | 57.14% |
| Dec 31, 2023 | 53.58M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 4.75M | 4.15M | 690.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| M.O.B.A. Network AB | 235.76M |
| Diadrom Holding AB | 46.70M |
| Compodium International AB | 46.02M |
| Divio Technologies AB | 37.60M |
| Zaplox AB | 18.44M |
| XMReality AB | 18.21M |
| Qlucore AB | 10.36M |
| Spotr Group AB | 8.23M |
Vaxxa AB News
- 15 days ago - Vaxxa AB Quarterly report: Q2 2026 - Filings
- 3 months ago - Vaxxa AB Quarterly report: Q1 2026 - Filings
- 5 months ago - Vaxxa AB Annual report: Q4 2025 - Filings
- 5 months ago - Vaxxa AB Quarterly report: Q4 2025 - Filings
- 10 months ago - Vaxxa AB Quarterly report: Q3 2025 - Filings